Background: The emergence of antibiotic-resistant Helicobacter pylori strains in recent years has increased the need for finding an alternative in the post-antibiotic era.
| INTRODUC TI ON
Infectious diseases affect the large number of people every year, and antibiotics are used to treat a wide variety of infections.
However, the emergence of antibiotic-resistant bacterial strains has led to a high rate of mortality. 1, 2 Based on the recent report of World Health Organization (WHO), the world has entered the post-antibiotic era in which many of the available options for the treatment of common infections are being ineffective and these infections can cause death. Therefore, without immediate effective actions, the antibiotic resistance will cause serious consequences. 3 The emergence of antibiotic-resistant microbial strains has increased the need for research and introduction of new types of antimicrobial compounds. Among the introduced compounds in this context, antimicrobial peptides can be suitable candidates to replace the antibiotics. 4, 5 Antimicrobial peptides (AMPs) are produced by a variety of organisms and their cells and are responsible for protecting the host against the pathogens, as a component of innate immunity. These peptides often contain <50 amino acids and are known as amphipathic peptides. Antimicrobial peptides are capable of killing a wide range of pathogens with high levels of speed and performance. 6 The remarkable point is that they are also effective against multidrug-resistant (MDR) bacteria and the resistance to AMPs is relatively low. 7 One of the bacteria with increased resistant strains in the recent years is Helicobacter pylori. The spread of resistance has significantly reduced the effectiveness of antimicrobial therapies. 6 Some studies showed that the resistance rate of this bacteria against clarithromycin has increased by 30% in Japan and Italy, 50% in China, and 40% in Turkey, during the last decade. 8 On the other hand, H. pylori infection can increase the risk of several diseases such as gastritis, peptic ulcer, dysplasia, neoplasia, and gastric B-cell lymphoma. H. pylori is a class 1 carcinogen, and there is an association between the gastric cancer incidence and H. pylori high prevalence rate. Gastric cancer is the second most common malignancy and the 14th cause of death worldwide and is considered as a major epidemiologic problem of the 21st century. In addition to antibiotic resistance, high costs of treatment, side effects, inadequate treatment due to the poor drug compliance are among the problems of current therapies to combat this infection.
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In recent years, regarding the mentioned advantages of AMPs, many efforts have been made to determine the efficiency and mechanism of action of these peptides for the treatment of H. pylori. In this review, all the antimicrobial peptides with proved anti-H. pylori effects are investigated. Finally, we compared these peptides and assessed their common characteristics.
| S E ARCH S TR ATEGY
A two-stage systematic search was designed based on the keywords related to the topic.
First, all English studies including the introduction of an- Then, the references and also cited studies to our selected articles were also reviewed and the possible additional studies which provided information on the structure, mechanism, and source of any anti-H. pylori peptide were selected. 
| Pexiganan or MSI-78

| Mechanism of action
This peptide has an unstructured form in the solution, but when placed adjacent to the detergent or lipid (membrane environment), it creates anα-helical structure. 18 Investigating the interaction of pexiganan with the membrane has shown that the destructive effect of this peptide is mediated by forming toroidal pores in the bacterial membrane. 19 Probably, five positively charged amino acids (KILKK)
have the most important effect in the strong anti-H. pylori effect. 16 It has also shown that this peptide has a synergistic effect with betalactams for the treatment of endotoxic shock due to the properties of attacking the membrane and binding to the lipopolysaccharide (LPS).
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F I G U R E 1 Three-dimensional structure of TP4 as an example of α-helical antimicrobial peptide 21 
| Tilapia piscidins
Tilapia piscidin 4 (TP4) (FIHHIIGGLFSAGKAIHRLIRRRRR) and tilapia piscidin 3 (TP3) (FIHHIIGGLFSVGKHIHSLIHGH) are two cationic antimicrobial peptides of piscidins class containing 25
and 23 amino acids, respectively. These two peptides have α-helical structure ( Figure 1 ). 21 Piscidins were isolated from fish mast cells in 2001. 22 The evaluation of antimicrobial effect of five iso- 23 In the following years, conducted studies regarding the anti-H. pylori activity of tilapia piscidins (TPs) showed that TP4 (MIC = 1.5-3 µg/mL) was the most active member of this class and TP3 (MIC = 8-12 µg/mL) was the second one. 
| Cathelicidins
Cathelicidins are a family of AMPs first discovered in the bone marrow myeloid cells. They are usually stored in the secretory granules of neutrophils and macrophages and are involved in the innate immunity. 34, 35 The anti-H. pylori effect of two members of this family, human cathelicidin LL-37 and mouse cathelicidin CRAMP, has been proved so far. 36, 37 Investigations on mouse models showed the stronger colonization of H. pylori in cathelicidin knockout mice, F I G U R E 2 Ribbon diagrams of HNP1 dimer, an example of β-sheet structure antimicrobial peptides 82 along with lower expression of the anti-inflammatory cytokine IL-10 and higher expression of proinflammatory cytokines IL-6, IL-1b, and 
| Defensins
Defensins are a family of arginine-rich AMPs that are usually secreted by immune and epithelial cells of many living organisms. They are active against a wide range of pathogens, as a part of host immunity. They are divided into three subfamilies of α, β, and ϴ-defensins.
The mechanism of their bactericidal activity is not well defined yet.
The positive charge of peptide interacts with the negative charge of bacterial surface and causes the penetration of defensins into the membrane lipids. These peptides seem to permeabilize the bacterial membrane and exert their bactericidal effect. 54, 55 So far, the anti-H. pylori effect of two defensins has been reported. isolates. In addition to antibacterial effects, bicarinalin has antifungal (C. albicans, Aspergillus niger, and Saccharomyces cerevisiae) and antiparasitic (Leishmania infantum) activities. 65 It has no cytotoxic effect on human lymphocytes up to the 8.5 μmol/L concentration. 66 Also, the cytotoxic concentrations of 50% were measured at 39.2 and 1.7 μmol/L for peritoneal macrophage and gastric cell lines, respectively. 65 The mechanism of action for this peptide is not still clear, but probably it stops the bacterial growth by permeabilization mechanism, same to most of the amphipathic AMPs. As it has been shown, when the peptide inhibits bacterial growth, the leakage of cellular materials to the outside significantly increases. 66 This peptide can also inhibit the binding of H. pylori to the gastric cells. 
| Human neutrophil peptide 1
PGLa-AM1 is active against oral pathogens Streptococcus mutans and
Fusobacterium nucleatum and can bind to the LPS of E. coli, P. aeruginosa, and Porphyromonas gingivalis. As PGLa-AM1 has no effect on the viability of oral fibroblasts, it can be used in the treatment of oral and dental infections. 69 
| Bacteriocins
Bacteriocins are the type of toxins (usually peptides) produced by bacteria and are responsible for inhibiting the growth of some other bacterial groups. Their spectrum of activity can be wide or narrow.
Many bacteriocins are produced by bacteria which are among probiotics. 73 So far, anti-H. pylori effects have been proved for some bacteriocins produced by probiotics. These investigations are generally In exposure to antibiotics (amoxicillin, ampicillin, and erythromycin), three DSM strains were 2 to 3 times more sensitive than the ATCC 43504.
Interestingly, DSM strains were also more sensitive than ATCC 43504 when exposed to the bacteriocins. 74 The best-known bacteriocin among these seven cases is Nisin A (ITSISLCTPGCKTGALMGCNMKTATCHCSIHVSK) which is used as a food preservative in more than 80 countries. Nisin A, similar to vancomycin antibiotic, first attaches to lipid II (an essential precursor for cell wall synthesis) and then develops the pore formation.
Lipid II serves as an anchor for nisin A and also facilitates the pore formation of this AMP by 1000-fold. 75 According to the antimicro- 
| Pediocin BA28
This bacteriocin is produced by probiotic Pediococcus acidilactici BA28. The study on the anti-H. pylori effect of pure Pediocin BA28 using well-diffusion test showed that it could inhibit the growth of H. pylori. It has also been showed that the activity of this peptide is dose-and time-dependent, as the complete eradication of H. pylori occurred within 24 hours at the 500 μg/mL dose. 78 The mechanism of action and precise sequence of this peptide is not still clear, 
| SUMMARY
To conclude and find the common features among all anti-H. pylori AMPs, the most studied cases were selected, and all of their important characteristics are provided in Table 2 . Also, the peptide molecular weight, peptide isoelectric point, and the charge of these peptides were calculated using protein isoelectric point calculator (https://isoelectric.org/index.html) and included in Table 2 .
Although some of these features such as peptide isoelectric point and electric charge have been reported as different values in various studies, we evaluated all peptides with uniform software (protein isoelectric point calculator). Also, MICs of E. coli and S. aureus were extracted from different studies and added for comparison. In the cases in which several strains were evaluated, the MIC was reported in a range from the lowest to the highest values.
According to our data in Table 2 , the results and evaluation of similarities among AMPs with reported anti-H. pylori effects are as follows:
1. All of these AMPs are cationic and have a positive charge in the pH of 7.4.
2. Most of these AMPs have α-helical structure (Figure 1 ).
3. The strongest anti-H. pylori effect is related to three AMPs pexiganan, tilapia piscidin 4 (TP4), and PGLa-AM1. They are all α-helical, and in addition to having the pI (isoelectronic point) above 11, they have also strong positive charge. So, it can be concluded that the positive charge and high pI can both be directly correlated with the bactericidal effect in α-helical AMPs, while this correlation does not seem to exist for β-sheeted AMPs (Figure 2 ), according to our results.
4. The sequence comparison of evaluated AMPs using Mega software 81 did not show any significant similarities that include all of these peptides.
5. All of AMPs with anti-H. pylori effects that have been identified so far have the molecular weight of 1.99-4.4 kDa.
6. Although further studies are required to discover all the mechanisms regarding anti-H. pylori effects of these AMPs, the most known mechanism to date is related to the pore-forming activity.
